Bernard Katz Building UCL
09:30 – 10:00 | Arrival & Refreshments | |
10:00 – 10:05 | Welcome & Introductions | Martina Micheletti |
10:05 – 10:30 | Vax-Hub overview & progress update | Martina Micheletti & Nav Gil |
Technology Showcases | ||
10:30 – 11:00 | Malaria vaccines: the R21 story | Adrian Hill, The Jenner Institute |
11:00 – 11:30 | Adenovirus vectors as a vaccine platform | Sandy Douglas, The Jenner Institute |
11:30 – 12:00 | Development and production of low-cost recombinant glycoconjugate vaccines | Brendan Wren, LSHTM |
12:00 – 12:30 | Flash Poster Presentations Vax-Hub Researchers | |
12:30 – 14:00 | Lunch, Networking & Poster Session | |
User Group Interactions | ||
14:00 – 14:30 | End-to-End HTPD To Support Vaccine Process Development in a Resource Constrained Environment | Marc Wenger, Merck |
14:30 – 15:00 | PT Bio Farma: Overview of Life Science research and development | Neni Nurainy & Adriansjah Azhari, PT Bio Farma |
15:00 – 15:30 | Solid dose vaccine delivery | Ludovic Bonnet, Enesi Pharma Limited |
15:30 – 16:10 | Coffee & Networking | |
16:10 – 16:30 | Enhanced operational and economic tools for vaccine production and supply | Benoit Chachuat, Imperial College London |
16:30 – 16:45 | Next steps | Martina Micheletti & Sarah Gilbert |
16:45 – 18:00 | Drinks Reception & Networking |